Rekvina Laboratories Performance
- Today's Low
- ₹27
- Today's High
- ₹28
- 52 Week Low
- ₹7
- 52 Week High
- ₹47
- Open Price₹28
- Previous Close₹28
- Volume130
- 50 DMA₹35.50
- 100 DMA₹32.60
- 200 DMA₹25.60
Rekvina Laboratories Chart
Investment Returns
- Over 1 Month -28.97%
- Over 3 Month -38.31%
- Over 6 Month + 195.23%
- Over 1 Year + 491.11%
Smart Investing Starts Here Start SIP with Rekvina Laboratories for Steady Growth!
Rekvina Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -63
- PEG Ratio
- 0.7
- Market Cap Cr
- 16
- P/B Ratio
- -13.1
- Average True Range
- 1.2
- EPS
- -0.4
- Dividend Yield
- 0
- MACD Signal
- -2.3
- RSI
- 21.98
- MFI
- 54.89
Latest Stock News Updates
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulation 2018
- BSE India
- 6 days 20 hours ago
Open Offer Update
- BSE India
- 3 weeks ago
Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended ("SEBI (SAST) Regulations") Cum corrigendum to the detailed Public Statement for the attention of the Public Shareholders of Rekvina Laboratories Ltd ("''Target Company").
- BSE India
- 3 weeks ago
Rekvina Laboratories Financials
Rekvina Laboratories Technicals
EMA & SMA
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹33.70
- 50 Day
- ₹35.50
- 100 Day
- ₹32.60
- 200 Day
- ₹25.60
Resistance and Support
- R3 28.10
- R2 28.10
- R1 28.00
- S1 28.00
- S2 27.90
- S3 27.90
Rekvina Laboratories Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-05-21 | Audited Results | |
| 2026-03-16 | Preferential Issue of shares | Inter-alia, to consider 1.Proposal for issuance equity shares/any other securities of the Company, by way of Preferential issue, in accordance with provisions of Securities & Exchange Board of India. |
| 2026-02-06 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | (Revised) |
About Rekvina Laboratories
Rekvina Labs is engaged manufactures pharmaceutical products. The Company markets its products to healthcare providers, facilities, and researchers throughout India and internationally'. View More- NSE Symbol
- VINRKLB
- BSE Symbol
- 526075
- ISIN
- INE092O01028
Similar Stocks to Rekvina Laboratories
Popular Stocks
Rekvina Laboratories FAQs
Rekvina Laboratories share price is ₹26 As on 22 July, 2026 | 16:11
The Market Cap of Rekvina Laboratories is ₹16 Cr As on 22 July, 2026 | 16:11
The P/E ratio of Rekvina Laboratories is -63 As on 22 July, 2026 | 16:11
The PB ratio of Rekvina Laboratories is -13.1 As on 22 July, 2026 | 16:11
The 52 week High & Low of Rekvina Laboratories is ₹46.6/₹6.8 respectively As on 22 July, 2026 | 16:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.